by | Jun 24, 2024 | Publications
J Radiol Case Rep. 2024 Jun 1;18(1):14-19. doi: 10.3941/jrcr.v18i1.5240. eCollection 2024. ABSTRACT Multiple myeloma is a plasma cell neoplasm, which may present as a solitary plasmacytoma and, uncommonly, as an extramedullary plasmacytoma. Intracranial plasmacytomas...
by | Jun 24, 2024 | Publications
JACC Case Rep. 2024 Jun 8;29(14):102387. doi: 10.1016/j.jaccas.2024.102387. eCollection 2024 Jul 17. ABSTRACT We introduce the innovative use of technetium-99m-labeled macroaggregated albumin to diagnose high-output heart failure in a patient with multiple myeloma...
by | Jun 24, 2024 | Publications
Front Oncol. 2024 Jun 7;14:1353943. doi: 10.3389/fonc.2024.1353943. eCollection 2024. ABSTRACT INTRODUCTION: Extramedullary plasmacytoma (EMP) is an uncommon solitary tumor originating from neoplastic plasma cells located outside the bone marrow. Despite its rarity,...
by | Jun 24, 2024 | Publications
Clin Lymphoma Myeloma Leuk. 2024 May 31:S2152-2650(24)00223-4. doi: 10.1016/j.clml.2024.05.022. Online ahead of print. ABSTRACT INTRODUCTION: Existing literature suggests that women are significantly underrepresented in the field of hematology-oncology. Women make up...
by | Jun 22, 2024 | Publications
Cancer Cell. 2024 Jun 14:S1535-6108(24)00217-4. doi: 10.1016/j.ccell.2024.05.026. Online ahead of print. ABSTRACT Multiple myeloma (MM) is an incurable plasma cell malignancy that exploits transcriptional networks driven by IRF4. We employ a multi-omics approach to...
by | Jun 21, 2024 | Publications
Leukemia. 2024 Jun 20. doi: 10.1038/s41375-024-02303-w. Online ahead of print. ABSTRACT Multiple myeloma (MM) cells effectively escape anti-tumoral immunity to survive in the tumor microenvironment (TME). Herein, we identify non-classical major histocompatibility...
